Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Hansa Biopharma AB (HNSA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
27.20 -0.68    -2.44%
11:29:43 - Closed. Currency in SEK ( Disclaimer )
Type:  Equity
Market:  Sweden
ISIN:  SE0002148817 
S/N:  52671796
  • Volume: 200,575
  • Bid/Ask: 27.20 / 27.20
  • Day's Range: 26.46 - 27.68
Hansa Biopharma 27.20 -0.68 -2.44%

HNSA Recent Sentiments

 
This page contains information on users’ sentiments for the Hansa Biopharma AB stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Jan 11, 2024 Ante Yol   34.66 Feb 02, 2024 @ 31.32 -9.64%
Jan 08, 2024 Buzz l   30.28 Jan 15, 2024 @ 33.76 -11.49%
Dec 06, 2023 lau panduro   22.70 Dec 29, 2023 @ 26.38 -16.21%
Sep 19, 2023 Matti Vornanen   37.88 Nov 10, 2023 @ 25.20 +33.47%
Jul 21, 2023 lau panduro   43.90 Nov 30, 2023 @ 25.88 -41.05%
May 09, 2023 Susanna Barsum   53.50 Nov 30, 2023 @ 25.88 -51.63%
Apr 14, 2023 lau panduro   53.10 May 09, 2023 @ 55.30 +4.14%
Feb 20, 2023 Jason Roth   52.00 Mar 17, 2023 @ 48.62 -6.50%
Feb 16, 2023 Björn Domeij   51.75 Mar 10, 2023 @ 51.65 -0.19%
Feb 01, 2023 Tommy Larsson   62.25 Feb 06, 2023 @ 57.45 -7.71%
Jan 17, 2023 Fredrik Andersson   72.85 Feb 10, 2023 @ 54.20 -25.60%
Nov 03, 2022 Jan Frödén   53.30 Nov 28, 2022 @ 55.20 +3.56%
Aug 22, 2022 Jan Frödén   71.00 Sep 16, 2022 @ 58.95 -16.97%
Aug 05, 2022 Daniel Gustafsson   87.75 Aug 26, 2022 @ 63.70 -27.41%
Aug 01, 2022 bin zhu   83.80 Aug 26, 2022 @ 63.70 -23.99%
Jul 22, 2022 Marianne Molnar   84.60 Aug 13, 2022 @ 82.20 -2.84%
Jul 21, 2022 Maria Tyler   96.05 Aug 13, 2022 @ 82.20 -14.42%
Jun 16, 2022 محمود فرجانى   51.80 Jun 16, 2022 @ 51.70 -0.19%
Apr 08, 2022 Jakob Hansen   65.65 Apr 29, 2022 @ 54.60 -16.83%
Feb 03, 2022 Henryk Winsedal   64.52 Feb 07, 2022 @ 66.24 -2.67%
Jan 24, 2022 Jakob Hansen   69.34 Feb 18, 2022 @ 58.12 -16.18%
Jan 21, 2022 Henrik Persson   76.16 Feb 11, 2022 @ 69.00 -9.40%
Dec 23, 2021 Elias Martinsson   90.40 Jan 14, 2022 @ 78.84 -12.79%
Oct 25, 2021 Ulrik Pedersen   103.65 Nov 19, 2021 @ 98.40 -5.07%
Oct 14, 2021 Rasmus Hansen   113.00 Nov 05, 2021 @ 95.48 -15.50%
Sep 23, 2021 Jakob Hansen   129.25 Oct 15, 2021 @ 111.40 -13.81%
Sep 01, 2021 Sir Jarhawk   121.25 Sep 06, 2021 @ 128.10 +5.65%
Aug 09, 2021 Jakob Hansen   118.90 Sep 03, 2021 @ 130.00 +9.34%
Jul 28, 2021 Oskar Åhman   115.55 Aug 20, 2021 @ 116.25 +0.61%
Jul 21, 2021 Ulrik Pedersen   110.95 Aug 13, 2021 @ 118.35 +6.67%
Jul 20, 2021 Andreja Mitrovic   109.20 Aug 13, 2021 @ 118.35 +8.38%
Jul 02, 2021 Torben Zimmermann   145.60 Jul 23, 2021 @ 113.00 -22.39%
Jun 28, 2021 Peter Hovgaard   144.95 Jul 23, 2021 @ 113.00 -22.04%
Jun 21, 2021 Jakob Hansen   144.20 Jul 16, 2021 @ 109.70 -23.93%
May 26, 2021 Jakob Hansen   140.45 Jun 18, 2021 @ 150.25 +6.98%
May 07, 2021 Xuong Huynh   150.45 May 10, 2021 @ 149.90 -0.37%
Apr 09, 2021 Jakob Hansen   159.55 Apr 30, 2021 @ 168.35 +5.52%
Mar 18, 2021 Jackie Dang   149.50 Apr 09, 2021 @ 159.50 -6.69%
Feb 24, 2021 Ahmed Elmahdy   166.10 Mar 19, 2021 @ 152.30 -8.31%
Feb 12, 2021 Elzod Norboev   192.70 Mar 05, 2021 @ 148.40 -22.99%
Jan 15, 2021 NC Lilleøre   186.30 Feb 05, 2021 @ 178.00 +4.46%
Dec 29, 2020 Steven Bach   241.20 Jan 22, 2021 @ 183.80 +23.80%
Dec 18, 2020 Emil Wiktorsson   238.60 Jan 08, 2021 @ 216.00 -9.47%
Nov 23, 2020 Thor Nels Andersen   215.20 Dec 18, 2020 @ 240.60 +11.80%
Nov 10, 2020 Jens Hansen   254.40 Dec 04, 2020 @ 233.20 -8.33%
Oct 29, 2020 Josef Haghnegahdar   231.80 Nov 20, 2020 @ 231.80 0.00%
Oct 09, 2020 Emil Wiktorsson   252.40 Oct 30, 2020 @ 237.60 -5.86%
Sep 07, 2020 Henrik Nilsson   205.00 Oct 02, 2020 @ 238.80 +16.49%
Sep 02, 2020 Simon Valfridsson   204.80 Sep 25, 2020 @ 230.60 -12.60%
Sep 02, 2020 Göran Liss   205.00 Sep 25, 2020 @ 230.60 +12.49%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HNSA Comments

Write your thoughts about Hansa Biopharma AB
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
lau panduro
lau panduro Apr 02, 2024 8:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
think it's time to buy ... 2 strong quarter 💪
BumHunters Archer
JohnJenga Sep 06, 2021 6:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1630923594_18712.jpg
Run baby
Peter Hovgaard
Peter Hovgaard Sep 03, 2020 2:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.redeye.se/research/792767/hansa-biopharma-plattformspotential-driver-upp-vardering?utm_source=avanza&utm_medium=RSS
Peter Hovgaard
Peter Hovgaard Aug 26, 2020 2:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://news.cision.com/hansa-biopharma-ab/r/the-eu-commission-grants-conditional-approval-for-idefirix-tm---imlifidase--in-highly-sensitized-kid,c3181977
Peter Hovgaard
Peter Hovgaard Aug 14, 2020 8:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://streamio.com/api/v1/videos/5f3512566f8d8dd4d8000001/public_show
Peter Hovgaard
Peter Hovgaard Aug 13, 2020 5:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://cdn.fbsbx.com/v/t59.2708-21/117831693_1914597025350073_1554897188658194790_n.pdf/Intron-Health-Research-Initiation-Hansa-Biopharma-A-Rare-Gem.pdf?_nc_cat=111&_nc_sid=0cab14&_nc_ohc=7LrlyVybJasAX84jF3U&_nc_ht=cdn.fbsbx.com&oh=3f8350d7915c58e168cbd3df20773c00&oe=5F36E9BE&dl=1
Capstar Go
Capstar Go Jun 25, 2020 5:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Press releases & NewsHansa Biopharma receives positive CHMP opinion for Idefirix[TM] (imlifidase) for kidney transplant in EU
Capstar Go
Capstar Go Jun 25, 2020 4:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
CHMP recommendations approved
Harri Rautiainen
Harri Rautiainen Jun 11, 2018 5:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
152871054577145.jpg
Short-term dipping, in loger run a promising share.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email